about
sameAs
Interventions for the management of oral ulcers in Behçet's diseaseInterventions for the management of oral ulcers in Behçet's diseaseBehçet's disease: a new target for anti-tumour necrosis factor treatmentBehçet's diseaseColchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trialsMucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesA double-blind trial of depot corticosteroids in Behçet's syndromeGender Differences in Behçet's Disease Associated Uveitis.Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factorBiological treatments in Behçet's disease: beyond anti-TNF therapy.Behcet's Syndrome.The treatment of chronic recurrent oral aphthous ulcers.Number VII Behçet's disease (Adamantiades syndrome).Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.Treatment of neuro-Behçet's disease: an update.New Evidence-Based Treatment Approach in Behçet's Disease.Managing the symptoms of Behçet's disease.Outcome measures used in clinical trials for Behçet syndrome: a systematic review.Behçet's disease: a review.Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's diseaseLow Level Laser Therapy to Reduce Recurrent Oral Ulcers in Behçet's Disease.Colchicine: old and newMucocutaneous lesions of Behcet's diseaseThe prevalence and clinical characteristics of esophageal involvement in patients with Behçet's disease: a single center experience in KoreaIntestinal complications of Behçet's diseaseBehçet's syndrome in pregnancy.Managing Behçet's disease: An update on current and emerging treatment options.Update on the diagnosis and management of Behçet's disease.Evidence-based practice in Behçet's disease: identifying areas of unmet need for 2014.The great masquerader: Behcet's disease.Update on the therapy of Behçet disease.Neutrophilic dermatoses: part I.Behçet syndrome: is it one condition?Differential diagnosis and management of Behçet syndrome.Etiology and therapeutic management of erythema nodosum during pregnancy: an update.Approaches to immunosuppression in Behçet's disease.Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.Therapy of ocular Behçet disease.Behçet syndrome: from pathogenesis to novel therapies.Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
P2860
Q24193450-44EE7182-ED7E-48AB-A043-070E1D1C760BQ24198926-EAD54413-8EFD-4406-BEF5-BC1FDD53CCBBQ24675071-B1B8CEAF-C39F-4C45-A81A-7EA25AF71860Q24804631-DC5FB590-5B2D-4A6D-830B-DB2320DF47AFQ26796341-3975C208-AE0A-443D-A1BC-75E740A2752EQ26799767-428972BA-B493-486D-8DCF-17A65D3631F6Q28279953-A1160EAD-A6AF-42E6-9D1D-0A1F25257A2AQ33597470-E839656D-2F48-48F8-9881-EDCEB81FFD87Q33806649-8A3ABF34-544F-4904-8644-2DA2EC47E2E9Q33908217-6F81F491-E63D-4085-93AF-AC631AE893EDQ34311953-98341CFE-E4FF-4D5C-A35E-8986F2832C06Q34430267-1E4A1DFF-ADB7-4BB4-8D3A-1BFF4B4483D5Q34494125-2942BBD4-9019-4BCF-8BB8-D0752281A98DQ34635091-19E36AD9-9C29-465C-A923-03D48C1E7732Q34974052-0779F1C0-7D1C-4CF5-98D0-87B3765F87EEQ35295186-39A4F38C-0A86-4395-A402-807F772F78D6Q35680592-5C987577-8A4E-43D4-B7C4-86036AB2881FQ35868282-422C7A81-D7E0-4AC4-9DC3-F94BD7081145Q36050822-B62B4AE5-C547-406F-B98D-B279AC0E6978Q36073870-B6B477F2-7C4E-41ED-BB67-65FC0A4EAA9AQ36111189-F31ED1BE-A251-4F9C-952C-64D12FB1F691Q36384995-B1AE30EC-72B6-4FD4-ACE4-AB5957AC2CE8Q36920297-81DBAA38-7FC1-4C21-8635-DDFC78CABB8DQ37116839-7A506DDB-B013-426B-B32B-2C37BFDFFF31Q37146101-F74A252B-8B5B-46A0-9035-AE3325511274Q37186394-98F3DA82-8EA1-4730-A0AB-1967B36A79DFQ37230348-218F0D4D-A690-458E-8DC9-37161B4B00D4Q37301191-8AE70F25-7F5B-41D5-A1E8-3CB20906FF0CQ37539557-D46A0965-3567-44FC-8346-F76BF62CF5D6Q37711766-5A2AB906-117D-4053-9780-4EB4380C9363Q37712230-1669EFB0-6605-4853-A34F-A815E5123C01Q37857731-480C7C7A-CFD0-472F-8414-48BB3DF2C3C8Q38016755-3F91682F-95EF-41F7-9668-77BC8E98FEECQ38046118-72B22656-729F-4DE6-9DE4-E58B75011B9BQ38102593-633D216F-A5D3-4B88-8C53-BF26CD565B6BQ38119551-036A7F09-FE4F-4524-BA3E-35F0D8E300FAQ38136748-3C0A7872-FF49-4BDF-8F8F-DB52E78243D8Q38174652-FEB8392E-D8EF-4BBD-9ED5-0886ED5E77C3Q38275100-1F511B2A-CC97-4093-9896-2488B6EED7F2Q38495475-009D200C-F07E-4AA1-82A0-6AC30918E98D
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A double-blind trial of colchicine in Behçet's syndrome
@ast
A double-blind trial of colchicine in Behçet's syndrome
@en
A double-blind trial of colchicine in Behçet's syndrome
@nl
type
label
A double-blind trial of colchicine in Behçet's syndrome
@ast
A double-blind trial of colchicine in Behçet's syndrome
@en
A double-blind trial of colchicine in Behçet's syndrome
@nl
prefLabel
A double-blind trial of colchicine in Behçet's syndrome
@ast
A double-blind trial of colchicine in Behçet's syndrome
@en
A double-blind trial of colchicine in Behçet's syndrome
@nl
P2093
P2860
P3181
P1476
A double-blind trial of colchicine in Behçet's syndrome
@en
P2093
S Yurdakul
V Hamuryudan
Y Ozyazgan
P2860
P304
P3181
P356
10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H
P407
P577
2001-11-01T00:00:00Z